Mechanistic determinants of MBNL activity
- PMID: 27733504
- PMCID: PMC5137450
- DOI: 10.1093/nar/gkw915
Mechanistic determinants of MBNL activity
Abstract
Muscleblind-like (MBNL) proteins are critical RNA processing factors in development. MBNL activity is disrupted in the neuromuscular disease myotonic dystrophy type 1 (DM1), due to the instability of a non-coding microsatellite in the DMPK gene and the expression of CUG expansion (CUGexp) RNAs. Pathogenic interactions between MBNL and CUGexp RNA lead to the formation of nuclear complexes termed foci and prevent MBNL function in pre-mRNA processing. The existence of multiple MBNL genes, as well as multiple protein isoforms, raises the question of whether different MBNL proteins possess unique or redundant functions. To address this question, we coexpressed three MBNL paralogs in cells at equivalent levels and characterized both specific and redundant roles of these proteins in alternative splicing and RNA foci dynamics. When coexpressed in the same cells, MBNL1, MBNL2 and MBNL3 bind the same RNA motifs with different affinities. While MBNL1 demonstrated the highest splicing activity, MBNL3 showed the lowest. When forming RNA foci, MBNL1 is the most mobile paralog, while MBNL3 is rather static and the most densely packed on CUGexp RNA. Therefore, our results demonstrate that MBNL paralogs and gene-specific isoforms possess inherent functional differences, an outcome that could be enlisted to improve therapeutic strategies for DM1.
© The Author(s) 2016. Published by Oxford University Press on behalf of Nucleic Acids Research.
Figures
Similar articles
-
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. doi: 10.1242/jcs.02404. Epub 2005 Jun 16. J Cell Sci. 2005. PMID: 15961406
-
(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.PLoS One. 2019 May 22;14(5):e0217317. doi: 10.1371/journal.pone.0217317. eCollection 2019. PLoS One. 2019. PMID: 31116797 Free PMC article.
-
Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.Nucleic Acids Res. 2007;35(16):5474-86. doi: 10.1093/nar/gkm601. Epub 2007 Aug 15. Nucleic Acids Res. 2007. PMID: 17702765 Free PMC article.
-
The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.Differentiation. 2006 Mar;74(2-3):65-80. doi: 10.1111/j.1432-0436.2006.00060.x. Differentiation. 2006. PMID: 16533306 Review.
-
Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy.Int J Mol Sci. 2019 Jul 9;20(13):3365. doi: 10.3390/ijms20133365. Int J Mol Sci. 2019. PMID: 31323950 Free PMC article. Review.
Cited by
-
AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1.Nucleic Acids Res. 2020 Mar 18;48(5):2531-2543. doi: 10.1093/nar/gkaa007. Nucleic Acids Res. 2020. PMID: 31965181 Free PMC article.
-
The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1.Nat Cell Biol. 2017 Jul;19(7):820-832. doi: 10.1038/ncb3538. Epub 2017 May 29. Nat Cell Biol. 2017. PMID: 28553938
-
Partners in crime: Proteins implicated in RNA repeat expansion diseases.Wiley Interdiscip Rev RNA. 2022 Jul;13(4):e1709. doi: 10.1002/wrna.1709. Epub 2022 Feb 28. Wiley Interdiscip Rev RNA. 2022. PMID: 35229468 Free PMC article. Review.
-
Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.PLoS One. 2022 Jul 1;17(7):e0269683. doi: 10.1371/journal.pone.0269683. eCollection 2022. PLoS One. 2022. PMID: 35776705 Free PMC article.
-
Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.PLoS One. 2020 May 14;15(5):e0224912. doi: 10.1371/journal.pone.0224912. eCollection 2020. PLoS One. 2020. PMID: 32407311 Free PMC article.
References
-
- Pascual M., Vicente M., Monferrer L., Artero R. The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation. 2006;74:65–80. - PubMed
-
- Kanadia R., Johnstone K., Mankodi A., Lungu C., Thornton C., Esson D., Timmers A., Hauswirth W., Swanson M. A muscleblind knockout model for myotonic dystrophy. Science. 2003;302:1978–1980. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
